Pune, India -- (SBWIRE) -- 01/17/2020 -- The report on Drug Discovery Technologies Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024. According to the report the global drug discovery technologies market is expected to grow at a CAGR of 18.4% over the forecast period of 2018 - 2024.

For More Details Get FREE Sample Pages of this Premium Global Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1128

Drug Discovery Technologies Market: Drivers and Opportunities

The growing incidences of diseases, pathogen resistance to old drugs, patent expiries, and competition among drug manufacturers are the key factors that drive the growth of this market. Moreover, increasing investment in the field of nanotechnology, biotechnology, genomics, and, molecular biology are some other factor that has driven this market. Furthermore, the long duration of the drug discovery process, high initial setup cost and the presence of strict regulatory surroundings.

Drug Discovery Technologies Market: Segmentation

The report on the global drug discovery technologies market covers segments such as technology type and end-users. The technology type segments include biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology, and others (RNAi, combinatorial chemistry). On the basis of end-users, the global drug discovery technologies market is categorized into biopharmaceutical companies, pharmaceutical companies, research institutes, and biotech companies.

Ask Discount for the Latest Research Report @ https://www.infiniumglobalresearch.com/reports/request-discount/1128

Drug Discovery Technologies Market: Regional Insights

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and the Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016 – 2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, and Malaysia among others.

The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2018 - 2024.

Drug Discovery Technologies Market: Competitive Landscapes

The report provides profiles of the companies in the global drug discovery technologies market such as Agilent Technologies, Inc, Abbott Laboratories, Inc., GE Healthcare Ltd., Albany Molecular Research Inc., Affymetrix Inc., Arqule Inc., Luminex Corporation, Bayer Healthcare AG, Novartis AG, and AstraZeneca Plc.

Browse Complete Global Report and Detailed TOC: https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-drug-discovery-technologies-market

About us

The Infinium Global research comprises of a team of well-experienced analysts who have qualified in generating incisive reports. The breast reconstruction market report offers trends, opportunities, challenges, market size, and forecast for major geographical regions and key countries. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the drug discovery technologies market.